Active, not recruitingPhase 3NCT05326464

Tofacitinib in Recurrent GBM Patients

Studying Germ cell tumor

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Texas Southwestern Medical Center
Principal Investigator
Michael Youssef, MD
Assistant Professor
Intervention
Tofacitinib 10mg(drug)
Enrollment
17 target
Eligibility
18 years · All sexes
Timeline
20222027

Study locations (1)

Collaborators

Pfizer

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05326464 on ClinicalTrials.gov

Other trials for Germ cell tumor

Additional recruiting or active studies for the same condition.

See all trials for Germ cell tumor

← Back to all trials